Cargando…

Molecular Pathways in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension is a multifactorial, chronic disease process that leads to pulmonary arterial endothelial dysfunction and smooth muscular hypertrophy, resulting in impaired pliability and hemodynamics of the pulmonary vascular system, and consequent right ventricular dysfunction. Exi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Aangi J., Vorla, Mounica, Kalra, Dinesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456336/ https://www.ncbi.nlm.nih.gov/pubmed/36077398 http://dx.doi.org/10.3390/ijms231710001

Ejemplares similares

New Drugs and Therapies in Pulmonary Arterial Hypertension
por: Shah, Aangi J., et al.
Publicado: (2023)

Role of Lipid-Lowering Therapy in Peripheral Artery Disease
por: Belur, Agastya D., et al.
Publicado: (2022)

Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes
por: Beckmann, Taylor, et al.
Publicado: (2022)

Myocarditis associated with COVID-19 and its vaccines - a systematic review
por: Rout, Amit, et al.
Publicado: (2022)

A Rapidly Growing Cardiac Mass—Malignant or Benign?
por: Rout, Amit, et al.
Publicado: (2023)

Pulmonary arterial hypertension: Advances in pathophysiology and management
por: Chopra, Sandeep, et al.
Publicado: (2012)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Leopold, Jane A., et al.
Publicado: (2016)

Novel Treatment Pathways in Pulmonary Arterial Hypertension
por: Qaiser, Kanza N., et al.
Publicado: (2021)

The molecular targets of approved treatments for pulmonary arterial hypertension
por: Humbert, Marc, et al.
Publicado: (2016)

Pulmonary arterial hypertension: Cellular and molecular changes in the lung
por: Maron, Bradley A.
Publicado: (2020)

Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations
por: Schwaiger, Johannes P., et al.
Publicado: (2013)

Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension
por: Fazal, Shahood, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension
por: Lang, Irene M., et al.
Publicado: (2015)

The Molecular Genetics and Cellular Mechanisms Underlying Pulmonary Arterial Hypertension
por: Machado, Rajiv D.
Publicado: (2012)

Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension
por: Martin de Miguel, Irene, et al.
Publicado: (2023)

Channelopathy Genes in Pulmonary Arterial Hypertension
por: Welch, Carrie L., et al.
Publicado: (2022)

Beyond a single pathway: combination therapy in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2016)

Macitentan for the treatment of pulmonary arterial hypertension
por: Kholdani, Cyrus A, et al.
Publicado: (2014)

The Glycobiology of Pulmonary Arterial Hypertension
por: Vang, Shia, et al.
Publicado: (2022)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

Pregnancy in pulmonary arterial hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again
por: Prins, Kurt W., et al.
Publicado: (2018)

The physiological basis of pulmonary arterial hypertension
por: Naeije, Robert, et al.
Publicado: (2022)

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
por: Koudstaal, Thomas, et al.
Publicado: (2020)

Recent advances in pulmonary arterial hypertension
por: Wilkins, Martin R., et al.
Publicado: (2018)

Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions?
por: Summer, Ross, et al.
Publicado: (2011)

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015)

Pediatric Perioperative Pulmonary Arterial Hypertension: A Case-Based Primer
por: Shah, Shilpa, et al.
Publicado: (2017)

Genetics and Genomics of Pediatric Pulmonary Arterial Hypertension
por: Welch, Carrie L., et al.
Publicado: (2020)

Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension
por: Tofovic, Stevan P., et al.
Publicado: (2019)

Pulmonary arterial hypertension: an update
por: Hoendermis, E. S.
Publicado: (2011)

Preventive Saline Irrigation of the Bile Duct to Reduce the Rate of Residual Common Bile Duct Stones Without Intraductal Ultrasonography: A Systematic Review and Meta-Analysis
por: Akbar, Usman A, et al.
Publicado: (2023)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Recent advances in the management of pulmonary arterial hypertension
por: Tsai, Halley, et al.
Publicado: (2016)

Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial Hypertension
por: Yao, Xiaoting, et al.
Publicado: (2021)

Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
por: Hernandez-Gonzalez, Ignacio, et al.
Publicado: (2021)

Diagnosis and management of pulmonary arterial hypertension
por: Cullivan, Sarah, et al.
Publicado: (2022)

Ambrisentan for the treatment of pulmonary arterial hypertension
por: Casserly, Brian, et al.
Publicado: (2009)

Inhaled treprostinil and pulmonary arterial hypertension
por: Nadler, Samuel T, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5osm8dd1kfekv1ikqm1rur6qnc